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ABSTRACT 
Background 
International evidence shows that mass media campaigns (MMCs) are effective 
tobacco control interventions. However, they require substantial investment; a 
key question is whether their costs are justified by their benefits. The aim of this 
study was to systematically and comprehensively review economic evaluations of 
tobacco control mass media campaigns. 
Methods 
An electronic search of databases and grey literature was conducted to identify all 
published economic evaluations of tobacco control mass media campaigns. 
Authors reviewed studies independently and assessed the quality of studies using 
the Drummond 10-point checklist. A narrative synthesis was used to summarise 
the key features and quality of the identified studies.  
Results 
Ten studies met the inclusion criteria and were included in the review. All the 
studies included a cost-effectiveness analysis, a cost-utility analysis or both. The 
methods were highly heterogeneous, particularly in terms of the types of costs 
included. On the whole, studies were well-conducted, but the interventions were 
often poorly described in terms of campaign content and intensity, and cost 
information was frequently inadequate. All studies concluded that tobacco control 
mass media campaigns are a cost-effective public health intervention.  
Conclusions 
The evidence on the cost-effectiveness of tobacco control mass media campaigns 
is limited, but of acceptable quality and consistently suggests that they offer good 
value for money. 
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BACKGROUND 
Tobacco use kills nearly 6 million people annually, and it is estimated that it will 
cause one billion deaths during the 21st century.[1] International evidence has 
shown that tobacco control mass media campaigns (MMCs) can increase smoking 
cessation and reduce smoking prevalence and uptake in adults.[2-4] There is also 
evidence that mass media can prevent the uptake of smoking in young people, 
although it is less robust.[5] Campaigns tend to convey messages about the 
negative health consequences of smoking or more positive messages, such as 
information about how to quit smoking. Some campaigns have also shown 
tobacco industry marketing tactics.[6 7] Commonly used media channels for 
tobacco control MMCs include television, the internet, radio, billboards and print 
media.[8] 
Mass media campaigns are able to deliver specific messages to large numbers of 
people; however, they require substantial upfront expenditures.[2 8 9] For 
example, developing a new advertisement in Australia in 2010, from initial 
research including concept development and production, required a minimum of 6 
months and on average cost $400,000AUD.[10] Existing guidelines recommend 
that governments in developed countries should spend about US$ 1.50-4.00 per 
person per year (approximately 15-20% of total tobacco control expenditures) on 
anti-tobacco counter advertisements and health communication.[8] In England, 
up to £38 million were spent on tobacco control marketing in 2009-10.[11]  
Given the costs associated with developing and implementing mass media 
campaigns, it is particularly important to establish whether the public health 
benefits of such campaigns are sufficient to justify these expenditures. Economic 
evaluation involves the identification, measurement and valuation of costs and 
benefits of health interventions to establish whether they offer value for money. 
To our knowledge, there is currently no peer-reviewed systematic review of 
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economic evaluations of tobacco control mass media campaigns. This study aims 
to identify and critically assess published economic evaluations of tobacco control 
mass media campaigns to establish whether they can be a worthwhile tobacco 
control intervention. 
 
METHODS 
This review was conducted according to the Centre for Reviews and 
Dissemination (CRD) guidance for undertaking systematic reviews of economic 
evaluations.[12] 
Search strategy 
A search strategy was developed to identify all published economic evaluations of 
tobacco control mass media campaigns. The following electronic databases were 
searched to identify relevant studies from inception to 15th May 2013: Medline, 
the Cochrane Library, Embase, PubMed, Web of Knowledge, the Health Economic 
Evaluations Database (HEED), the Cost Effectiveness Analysis registry (CEA), and 
the NHS Economic Evaluation Database (NHS EED). The literature search was re-
run on April 16th 2014 to identify any relevant studies published since the original 
search date. 
The search terms were developed in relation to the intervention, outcomes and 
designs of the studies. The search strategy for Medline, Web of Knowledge and 
Embase included both MeSH terms and free texts of the primary search terms. 
The search terms were: 
x Mass media 
x Campaign 
x Advert* 
x Marketing 
x Promot* 
x Social media 
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x Television 
x Radio 
x Billboard 
x Tobacco 
x Tobacco control 
x Cigarette* 
x Smok* 
x Tobacco use 
x Prevention 
x Reduction 
x Cessation 
x Quit 
x Economic evaluation 
x Cost effectiveness 
x Cost utility analysis 
x Cost benefit analysis 
x Cost effectiveness ratio 
 
The reference lists of retrieved articles were also searched to identify potentially 
relevant studies. In addition, other online grey literature was identified using 
Google and Google Scholar. http://www.theses.com/ was also searched for 
relevant studies.  Published articles without full texts online, but available in the 
University of Nottingham Library were also considered.  
Inclusion criteria 
This study used broad inclusion criteria to ensure that all economic evaluations of 
tobacco control mass media campaigns would be included. Studies considered 
suitable for inclusion were those which evaluated the costs and benefits of mass 
media campaigns.  
Study design 
We included studies which used standard economic evaluation designs such as 
cost-effectiveness analysis (CEA), cost-utility analysis (CUA) or cost-benefit 
analysis (CBA), as defined below: 
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x CEA: Benefits are measured in natural units (e.g. life years gained, 
smokers averted) to obtain an incremental cost per outcome (e.g. 
cost per additional quitter). 
x CUA: Benefits are measured using a measure of utility (QALYs or 
DALYs) to obtain an incremental cost per QALY gained/DALY 
averted. 
x CBA: Benefits are converted to monetary units to be compared with 
costs, deriving a cost benefit ratio. 
In both CEA and CUA, the main result is usually expressed as an incremental 
cost-effectiveness ratio (ICER) - the ratio of the change in costs to incremental 
benefits of an intervention. Policymakers can use this to help them decide if an 
intervention is an efficient use of resources, by making a judgment about the 
maximally acceptable cost-per-unit of outcome.  There is usually no explicit ICER 
threshold, although implicit cost-per-QALY thresholds have been estimated from 
funding allocation decisions e.g. Australia (AU$69,900/QALY), New Zealand 
(NZ$20,000/QALY), and Canada (acceptance up to CAN$80,000/QALY, rejection 
from CAN$31,000 to CAN$137,000/QALY).[13] 
Intervention 
A tobacco control mass media campaign was defined as using any of the following 
channels of communication to deliver a tobacco control message to a large 
population: television, radio, newspapers, billboards, internet, leaflets or 
booklets. The purpose of the mass media campaign had to be to reduce the 
harms caused by tobacco consumption, for example by encouraging cessation, 
reducing uptake, or reducing secondhand smoke exposure. The mass media 
campaign could be evaluated as a stand-alone intervention, or as a part of a 
wider tobacco control programme. All target populations were considered.  
Outcomes 
7 
 
All health and smoking-related outcomes were included; it was anticipated that 
the majority of studies would measure quit attempts, quitters, smokers averted, 
life years gained (a measure of the additional number of years lived as a result of 
an intervention), Quality Adjusted Life Years (a measure of the additional number 
of years lived as a result of an intervention adjusted for quality of life in those 
years) or Disability Adjusted Life Years (years of life adjusted for the effect of 
illness on disability). Studies which measured the cost per person to see an 
advert were excluded. 
Perspective 
Studies were included regardless of the perspective of the evaluation, i.e. they 
could take a narrow perspective, such as the national health service, or a broad 
societal perspective. 
Identification of papers 
The lead reviewer (EA) conducted the literature search to identify relevant 
studies. Two reviewers screened the title and abstracts of the returned citations 
and considered them for inclusion using the criteria above. Full texts of 
potentially relevant articles were retrieved and independently screened by both 
reviewers to determine whether a study should be included. Disagreements were 
resolved through discussion and reasons for exclusion recorded. 
Data extraction and quality assessment 
Data extraction and quality assessment were conducted by the lead reviewer and 
checked by a second reviewer. 
Data extraction focused on key methodological features - type of economic 
evaluation, analytical approach (real data vs. hypothetical modelling), outcome 
measures, study perspective, collection of cost data, time horizon, discounting, 
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sensitivity analyses) - and the nature of the intervention (setting, target 
population, type of mass media, duration, main campaign message). Background 
characteristics such as authors and years of study and publication were also 
extracted. 
Quality assessment was conducted using the most widely used checklist for 
assessing the quality of economic evaluations, the BMJ checklist.[12 14] Although 
there are scoring systems for assessing the quality of economic evaluations, 
existing evidence suggests that they are not sufficiently valid and reliable, and 
the CRD guidelines recommend these are not used.[12]  
Due to substantial heterogeneity between the studies, a meta-analysis was not 
possible. A narrative synthesis of the identified studies was used to summarise 
the key features of the identified studies, and compare study question, 
interventions, methods and results. We present descriptive critical assessment 
based on the BMJ checklist and summarise the quality of the studies using the 
Drummond 10-point checklist. [15] This checklist covers the same main points as the 
BMJ checklist but is a quicker tool for assessing the quality of studies. 
RESULTS 
The electronic search in May 2013 identified 842 studies. One further study was 
identified by hand search of the reference lists of the included studies, making a 
total of 843 potential studies. Screening by title reduced this to 65. Abstract 
screening reduced this further to 22 potential studies, which were retrieved for 
full text review. Following full text review, a further 12 studies were excluded, 
leaving 10 studies to be included in the review. [16-25] One of these studies was 
a report published by NICE; all others were studies published in peer-reviewed 
journals. [20] A further relevant study in a peer reviewed journal was identified in 
the updated literature search.[26]  A flow diagram of the selection of studies and 
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a list of studies excluded at the full text review stage, including reasons for 
exclusion, is included in supplementary online material (Appendix 1-3). 
Characteristics of studies 
Table 1 reports the key characteristics of the included studies. Six studies were 
CEA,[16-19 24 26] three were CUA,[20 21 23] and two included both a CEA and 
a CUA [20 22]. All but two of the seven most recent studies included a CUA. 
There was wide variety between the included studies in terms of target 
population and type of mass media campaign.  
In four studies the campaign targeted people under the age of 18;[17 19-21] in 
two, adults were targeted.[16 25] In four studies the campaign was aimed at the 
general population [22-24 26]. One targeted a specific demographic group ± the 
Turkish community in London.[18] 
Eight studies were based on real-life mass media campaigns and extrapolated the 
outcomes of those campaigns to obtain long-term cost-effectiveness [16-18 22 
24 26] or cost-utility estimates.[21 22 25] Three studies used data on the impact 
of mass media campaigns to model the impact of hypothetical campaigns.[19 20 
23]  
All the mass media campaigns aimed to reduce smoking by preventing uptake or 
encouraging cessation. No studies reported that the campaigns aimed to reduce 
exposure to secondhand smoke. The types and number of media channels used 
varied between studies, although all except one reported the use of  television 
advertising[20]. In other studies, radio, [17 21 23 25 26] a range of print media 
[16 21 23 26] and internet-based media were used [21 23 26]. One study 
reported the impact of a campaign which included a free telephone helpline and 
therefore did not just look at the effect of mass media.[16] Other studies 
considered effects of mass media in conjunction with other tobacco control 
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interventions, but provided the results specific to the mass media campaign 
component, which have been reported in this review.[19 20 23] One study, based 
on a hypothetical campaign, did not report which media were assumed to have 
been used.[20] The duration of exposure was not always specified, but varied 
from an annual one-day campaign [24] to multiple campaigns over a five year 
period. [23] 
The perspective of the economic evaluations also varied substantially, from very 
narrow, such as that of the organisation running the campaign, [16-18 24 26] 
which tended not to include future healthcare costs, to wider perspectives where 
future healthcare costs were taken into account.[19-23 25] 
All studies reported an incremental analysis and made favourable conclusions 
regarding the cost-effectiveness of the mass media campaigns. Some studies 
reported that mass media campaigns were cost saving when future healthcare 
costs were taken into account;[21-23] others that took into account further 
healthcare costs did not find that campaigns were cost saving.[19 20 25] The 
ICERs varied substantially even between studies using the same measure of 
benefit; this can be explained by the substantial variations in types and 
intensities of campaigns, study perspectives and costing methods (explained 
further below). The highest base case ICER was $37,355 per QALY (price year 
2009).  
The ICERs also varied substantially within studies, depending on the assumptions 
made. However, even when pessimistic assumptions were used in sensitivity 
analysis (i.e. higher costs and/or less effectiveness), results generally suggested 
that the evaluated campaign was cost-effective. For example, a study based on a 
campaign targeting adolescents found that using optimistic assumptions the 
campaign was cost-saving; in the pessimistic case the ICER was $4302 per 
QALY.[21]  
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Overall, substantial methodological heterogeneity between the studies makes it 
difficult to compare estimates between studies. In particular, no pattern emerged 
which indicated that a particular type of campaign, for example those targeted as 
young people, was more likely to be cost-effective than others.
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Table 1. Data extraction 
Author/ 
year/country 
Population Intervention / 
Comparator 
Effectiveness  
Data 
Measure(s) 
of benefit 
Cost data Reported 
perspective / 
Discounting / 
Time horizon 
Sensitivity 
analysis 
Results 
Hurley et al, 
2008, Australia 
[22] 
General 
population 
National Tobacco 
Campaign, June-
November 1997, 
graphic anti-smoking 
television 
advertisements / No 
intervention 
Effectiveness of NTC on 
prevalence estimated 
from survey data. Markov 
model used to estimate 
future health benefits 
LYG, QALYs  Cost of campaign 
adjusted to $A10.1 in 
2001 $A. Healthcare 
cost estimated from 
existing literature, 
Future savings 
estimated using Markov 
model (Lung cancer, 
AMI, stroke, COPD 
only).  
Health care / 
3% / Lifetime 
Assume only half 
of reduction in 
smoking 
prevalence 
observed 
attributable to 
campaign. 
Prevention of 55 
000 deaths, gains 
of 323 000 LYs 407 
000 QALYs, 
Healthcare cost 
savings $A740.6m. 
Campaign remained 
cost saving in 
sensitivity analysis. 
Higashi et al, 
2011, Vietnam 
[23] 
General 
population 
Hypothetical mass 
media campaigns 
implemented over 5 
years (TV, radio, 
newspaper, journal, 
internet and electronic 
billboards) / No 
intervention 
Effect of campaigns on 
uptake and cessation 
estimated from literature. 
Markov model used to 
estimate future health 
benefits. 
DALYs Costed using WHO 
CostIt programm, 2006 
VND: Human resources 
requirements, media 
and advocacy, 
overheads. Healthcare 
cost savings for IHD, 
COPD and lung cancer. 
Government / 
3% / Lifetime  
ICER with and 
without 
healthcare cost 
offset. 
Without cost offset: 
VND 78300 per 
DALY averted (95% 
CI: 43,7000 ± 
176,300). With cost 
offset: Campaign 
dominates 
Kotz et al, 
2011, UK [24] 
General 
population 
No Smoking Day 
(NSD), 1 day per year 
since 1984 ± national 
campaign aiming to 
create supportive 
environment and 
highlight available 
help for people who 
want to quit. National 
social marketing 
campaign / No 
intervention 
Effect of NSD estimated 
from monthly survey data 
on quit attempts. 
Previously published 
model of cost-
effectiveness for smoking 
interventions used to 
estimate permanent rate 
of cessation and LYG. 
 
LYG Estimated from No 
Smoking Day charity, 
Report and financial 
statements ± 
approximately 
£750,000, price year 
not stated 
Organisational 
(NSD charity) / 
3.5% / Lifetime 
Assume that the 
true rate of 
permanent 
cessation 
attributable to 
NSD was only 
half 
that observed. 
 
ICER £82.24 per 
LYG (95% CI 49.7 
to 231.6) for 35-44 
year olds. £114.29, 
£76.19 and £97.45 
for age groups <35 
years, 45-54 years 
and 55-64 years 
respectively. 
Campaign remained 
cost-effective in 
sensitivity analysis. 
 
Brown et al, 
2014, UK [26] 
General 
population 
Stoptober ± a one-
month national 
campaign in 2012 
which set smokers the 
goal of being smoke-
free for October 
Effect of Stoptober 
estimated from monthly 
survey data on quit 
attempts. Previously 
published model of cost-
effectiveness for smoking 
interventions used to 
LYG Known costs of 
campaign obtained from 
Department of Health 
(2012 costs) 
Organisational 
(Department of 
Health) / 3.5% 
/ Lifetime 
Examined effects 
of modelling 
different 
adjustments for 
relapse. 
ICER for total 
population £558 per 
LYG (95% CI 126-
989). £414 for 35-
44 year olds, £607, 
417, 566 for <35 
year olds, 45-54 
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estimate permanent rate 
of cessation and LYG. 
 
year olds and 55-64 
year old 
respectively. 
Campaign remained 
cost-effective in 
sensitivity analysis. 
Ratcliffe et al., 
1997, Scotland 
[16] 
Adults  Campaign aiming to 
reduce smoking 
prevalence via TV, 
posters and press 
advertising, a 
telephone helpline and 
a booklet containing 
cessation advice, 
October 1992- 
October 1993 / No 
intervention 
1 year cessation rate 
assessed by survey of 
helpline callers. Modelling 
used to estimate LYG. 
LYG Retrospective analysis 
of costs of: 
Development and 
maintenance, mass 
media advertising, 
telephone helpline, 
information booklet, 
costs. Costs attributable 
to adults only. Mass 
media represented two 
thirds of total cost. Price 
year not stated. 
Organisational 
/ 6% benefits / 
Lifetime 
Variation of 
campaign costs 
and number of 
helpline callers. 
Cost per discounted 
LYG range from 
£304 to £656 when 
parameters are 
varied. 
Villanti et al, 
2012, USA 
[25] 
Adults EX campaign ± 
television and radio 
campaign designed to 
promote smoking 
cessation, March-
September 2008 / No 
intervention 
Survey used to estimate 
probabilities of confirmed 
awareness and quit 
attempts among those 
aware and those unaware 
of the EX campaign.  
National survey data 
used to estimate 
probability of quit 
attempts with no 
intervention.  Probability 
of successful quitting 
from existing literature. 
Number of QALYs gained 
per quit from existing 
literature. 
QALYs Intervention costs: 
Media, public relations, 
staff salaries. Other 
societal costs: Smoking 
cessation medication, 
behavioural therapy. 
Medical treatment costs 
saved by quitting 
smoking assumed to be 
$0. Price year 2009. 
Societal / 3% / 
Lifetime 
Variation of 
model 
parameters. 
Base case ICER 
$37,355. 
 
Sensitivity analysis: 
95% uncertainty 
interval $10,779-
204,976 per QALY. 
Fishman et al, 
2005, USA 
[19] 
18 year olds 
in USA 
Hypothetical 4 year 
MMC featuring 
regional and culturally 
relevant messages, 
using media outlets 
likely to reach 
adolescents / No 
intervention 
Years of potential life 
saved among cohort of 
18-year olds based on 
existing literature. 
LYG A range of assumed 
campaign costs based 
on existing literature - 
$0.31 per head, $0.97 
per head, $2.35 per 
head. Tobacco-
attributable health costs 
from existing literature. 
Price year 2000. 
Societal / 3%-
7%    / Lifetime 
Varying 
assumptions of 
campaign cost 
and discount rate. 
Cost per year 
potential life saved: 
$528 for low-cost 
media campaign 
with 3% DR, 
$19,957 for highest 
cost campaign with 
7% DR 
Secker-Walker 
et al, 1997, 
15-18 year 
old students 
4 year TV and radio 
MMC in addition to 
Difference in smoking 
prevalence between 
Smokers 
averted, LYG 
Campaign development 
and production cost 
Organisational 
/ 0%, 3%, 5% 
Different discount 
rates, different 
Community level: 
cost per smoker 
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USA [17] in 4 US cities school smoking 
prevention curriculum, 
1986-89. 36 TV ads 
and 17 radio ads 
specifically designed 
to appeal to students 
at different stages of 
adolescence / 
smoking prevention 
curriculum only 
students in communities 
receiving intervention 
and those in comparator 
communities. Markov 
model used to estimate 
LYG. 
from campaign records, 
price year 1996. Air-
time costs quoted by TV 
and radio stations. 
Costs estimated at 
community level and for 
whole of USA. 
/ Lifetime mass media 
effect sizes, 
different costs, 
halving LY lost 
due to smoking, 
variations in 
prevalence 
averted $754 
(95%CI 531-1296), 
cost per LYG at 3% 
DR $696 (95% CI 
445-1269) 
National level: cost 
per smoker averted 
$162, cost per LYG 
at 3% DR $138 
(95% CI 88-252) 
Campaign remained 
cost-effective in 
sensitivity analysis. 
Raikou & 
McGuire, 2008, 
UK [20] 
13-17 year 
olds in the 
UK. 
Hypothetical 5 year 
mass media 
campaign/ No 
intervention 
Effect on smoking 
prevalence estimated 
from the existing 
literature. Markov model 
used to estimate QALYs 
gained. 
QALYs, LYG Campaign costs based 
on 10x cost of 
education and 
communication 
programmes used to 
support implementation 
of smokefree legislation 
(price year not stated). 
Costs of treating 
smoking-related 
diseases from existing 
literature (2006 prices). 
Public health 
sector / 3.5% / 
Lifetime 
Varying 
assumptions of 
size of effect of 
intervention, cost 
of intervention 
and background 
quit rate. 
Base case: £49 per 
QALY gained, £362 
per LYG. Campaign 
remained cost-
effective in all 
sensitivity analyses 
Holtgrave et 
al., 2009, USA 
[21] 
12-17 year 
olds in USA 
National youth 
smoking prevention 
campaign (truth 
campaign), February 
2000-2002. TV radio, 
online and print media 
elements, a campaign 
tour that followed 
youth music events. / 
No intervention 
Smokers averted 
estimated in previous 
study. QALYs gained 
estimated using data 
from existing literature. 
QALYs Campaign cost data 
derived directly from 
expenditure records. 
Development and 
delivery of media 
elements, campaign 
tour, evaluation, 
litigation costs. Price 
year not stated, 
collected 2000-2002. 
Future healthcare costs 
saved estimated from 
existing literature (price 
year 2000). 
Societal / 3% / 
Lifetime 
Variation of 
smokers averted, 
QALYs gained per 
averted smoker, 
treatment costs 
saved. 
Base case: 178,290 
QALYs gained. 
Cost-saving. 
Optimistic case: 
1,050,000 QALYs, 
cost-saving. 
Pessimistic case: 
$4302 per QALY. 
Stevens et al, 
2002, UK [18] 
Turkish 
community 
in Camden 
and 
Islington, 
London, UK 
10 minute play, 
poster campaign, 
leaflets. 1996-97 
(Dates not specified) / 
No intervention 
Before and after panel 
survey used to estimate 
effect of intervention on 
quitting. Estimates of 1 
year quitters and LYG 
estimated from literature. 
1 year 
quitters, LYG 
Actual expenditure from 
project records ± salary 
costs, other labour 
costs, non-pay costs, 
overheads. Price year 
not stated, collected 
Local authority 
/ None / 
Lifetime 
 
Varying 
assumptions of 
population size, 
smoking 
population, quit 
rate, population 
Study reports mean 
cost-effectiveness 
drawn from 
probability 
distribution of 
possible outcomes 
15 
 
1996-97. smoking trend, 
continued 
abstinence, life 
years saved by 
quitting. Monte 
Carlo simulation. 
in sensitivity 
analysis. 
 
ICER £105 per LYG. 
(95% CI: £33-391) 
 
ICER 825 per one-
year quitter (95% 
CI: 300 ± 3500) 
 
 
 
Notes: LYG ± life years gained 
QALY ± quality-adjusted life year 
DALY ± disability-adjusted life year 
VND ± Vietnamese dollar 
$A ± Australian dollar 
16 
 
 
Quality assessment 
On the whole, studies were well-conducted bearing in mind substantial challenges 
associated with establishing effectiveness in population level public health 
interventions. As demonstrated in Table 2, the majority of studies had a clear 
research question, with a clear (although not usually explicitly stated) comparator 
RIµQRLQWHUYHQWLRQ¶, which was appropriate. One study compared a mass media 
campaign in addition to the school smoking prevention curriculum with the school 
smoking prevention curriculum only, which was equivalent to comparing with the 
status quo[17]. All the studies used a study design that was appropriate to the 
research question ± CEA or CUA ± with an incremental analysis and a sensible 
measure of benefit ± quit attempts, smokers averted, LYG, QALYs or DALYs. 
Furthermore, all studies attempted to demonstrate the long-run cost-
effectiveness of campaigns by using a lifetime horizon and conducted sensitivity 
analyses to allow for uncertainty in included parameters. 
None of the studies which reported using a societal perspective took into account 
wider societal costs such as the cost of absenteeism and may therefore be better 
defined as a healthcare perspective, although the healthcare sector may not have 
funded the campaigns. [19 21 25]  One study included campaign costs and health 
care costs but was reported as taking an organisational perspective. [17] Other 
studies included the same costs and defined the perspective as public health 
sector [20] and government.[23] Estimates of future heath care costs used 
varied; some studies assumed that there would be future healthcare cost savings, 
whereas others assumed that these savings would be offset by ex-smokers living 
longer.  
Several studies provided very limited detail about the mass media campaigns 
being investigated.[19-21 24] Similarly, several studies had weaknesses in the 
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reporting of costs. For example, one study reported an overall cost of a campaign 
with no breakdown of costs.[24] Ideally economic evaluations of mass media 
campaigns should present detailed breakdowns of the elements involved in 
developing and running campaigns and the associated costs. 
Estimating the effectiveness and long-run benefits of population-level public 
health experiments is known to be challenging. This is due to the nature of mass 
media campaigns, most of which are implemented at the population level and 
which therefore cannot be easily evaluated in controlled trials. Of the included 
studies, 8 out of 11 estimated the effectiveness of real life campaigns using 
primary survey data, or using existing estimates also based on surveys. These 
self-reported estimates of smoking behaviour are prone to underrecording, 
though  comparisons of the same outcomes before and after a campaign are less 
likely to be affected. Findings are also potentially subject to confounding by other 
simultaneous interventions. All of the included studies extrapolated short-term 
effectiveness results over long-run to estimate LYG, DALYs or QALYs by making 
assumptions about key parameters, such as the underlying quit rate, what 
proportion of quit attempts will be successful in the long-run and sustained 
effects on prevention. This introduced further uncertainty into final results, but 
was necessary to estimate long-term the benefits of the campaigns.  
Two of the included studies used monthly survey data on quit attempts collected 
over several years.[24 26] Although the monthly sample sizes were small, this 
enabled existing trends in quit attempts to be taken into account and robust 
comparisons to be made between periods with and without a mass media 
campaign. These data were extrapolated to estimate long-term cessation rates 
using data from the existing literature. Similarly, in another study the authors 
extrapolated data from a cohort survey on self-reported campaign awareness and 
quit attempts to estimate long-term successful cessation.[25] This is a standard 
approach, but introduces further uncertainty into the estimate of effectiveness. 
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This uncertainty is reflected by the very wide uncertainty interval reported in the 
study. 
Another study highlights the challenge of evaluating the effectiveness of a 
campaign in a small population with no regular data collection over time. In this 
study effectiveness was assessed using a small panel survey with a low rate of 
follow-up.[18] This approach seems reasonable given the setting, but introduces 
substantial uncertainty into the estimate of effectiveness: existing trends are not 
taken into account and it is difficult to determine a causal effect of the campaign. 
However, substantial sensitivity analysis in which several key parameters were 
YDULHGGLGQRWFKDQJHWKHVWXG\¶VFRQFOXVLRQV 
Three of the included studies used estimates of campaign effects from the 
existing literature; while it is reasonable to assume, based on existing literature, 
that mass media campaigns will be effective in both preventing uptake and 
increasing cessation, the specific estimates used are likely to be out-dated [19 
23]or not relevant to the study setting.[20 23] In two of the studies, a systematic 
review does not appear to have been carried out to determine the most suitable 
estimates  to use.[20 23] 
All of the studies conducted sensitivity analyses, which was particularly important 
bearing in mind the limitations in the estimates of effectiveness and long-term 
benefits. 
Most studies had a key element of benefits or costs that they were unable to take 
account of, and therefore the point estimates are unlikely to represent the true 
estimate. For example, one study estimated the benefits and cost savings for the 
cohort of 18 year olds only; the authors acknowledge that their estimate is 
conservative given that mass media campaigns also have an effect on adult 
smoking.[19].   
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Table 2. Quality assessment 
The 10-item Drummond checklist 
1. Was a well-defined question posed in answerable form? 
2. Was a comprehensive description of the competing alternatives given (i.e. 
can you tell who did what to whom, where, and how often)? 
3. Was the effectiveness of the programme or services established? 
4. Were all the important and relevant costs and consequences for each 
alternative identified? 
5. Were costs and consequences measured accurately in appropriate physical 
units (e.g. hours of nursing time, number of physician visits, lost work-days, 
gained life years)? 
6. Were the cost and consequences valued credibly? 
7. Were costs and consequences adjusted for differential timing? 
8. Was an incremental analysis of costs and consequences of alternatives 
performed? 
9. Was allowance made for uncertainty in the estimates of costs and 
consequences? 
10. Did the presentation and discussion of study results include all issues of 
concern to users?  
 
 
 
 
 
Yes =9 
No= X  
Not clear= 0 (in cases where the information provided was not satisfactory, 
thus making it difficult for the reviewer to make a conclusion) 
 
Author , year 1 2 3 4 5 6 7 8 9 10 
Raikou  9 x x 0 0 x 9 9 9 x  
Fishman  9 x  9 0  0  0  9 9 9 X  
 Ratcliffe  9 9 9 9  9 9 0 9 9 9 
Holtgrave  9 x  9 9 9 9 9 9 9 9 
Hurley  9 9 9 x  0 0  9  9  9 9 
Stevens  X  9 9 9 9 0 X  9 9  X  
Secker-Walker  9 9 9 9 9 9 9 9 9 9  
Kotz  9 x  9 0  0 0 9 9 9 x 
Villanti  9 9  9 9 9 9 9 9 9 X  
Higashi 9 9 x 9 9 9 9 9 9 9  
Brown 9 x 9 9 0 0 9 9 9 9 
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DISCUSSION 
This review found only 10 economic evaluations of tobacco control mass media 
campaigns. Most of these were found to be of acceptable quality, although 
methodologies varied substantially. Some evaluated campaigns which targeted 
adults, whereas others evaluated campaigns aimed at adolescents. All found the 
cost-effectiveness profile of the evaluated campaign to be favourable. 
The main strength of this review is that the broad search strategy ensured that all 
economic evaluations of mass media campaigns, regardless of setting and target 
population have been included. As a result, however, the types of campaigns and 
study methodologies were highly heterogeneous, making it difficult to compare 
studies and their results to draw definitive conclusions about which types of 
campaign are most cost-effective. In particular, this heterogeneity precluded the 
use of meta-analysis. This is consistent with a previous review of studies on the 
cost-effectiveness of health communication programs, which identified 
considerable variety in methodologies and hence problems of transparency, 
comparability and generalisability.[27]  
All of the included studies conducted incremental analyses and the majority of 
recent studies use CUA. In all the CUA, the interventions were either cost saving, 
or the ICERs were well below commonly used thresholds, even in the case of 
models using pessimistic assumptions.  The cost-effectiveness estimates varied 
substantially, however. Aside from variations in the nature of the interventions 
and their direct costs, this seems likely to stem from variations in assumptions 
about the impact of interventions on future health care costs. These were, in all 
studies, taken from existing data sources, but were not based on systematic 
reviews. Some studies assumed that the interventions would save healthcare 
costs in the future; some assumed that they would be offset by the costs of 
quitters living longer. Different studies also accounted for health care costs for 
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different diseases. For example, one study included only the health care cost 
savings for ischaemic heart disease, chronic obstructive pulmonary disease and 
lung cancer, and the cost savings may therefore have been underestimated.[22] 
A further factor contributing to heterogeneity in the ICERs between the studies is 
the variety between the applied estimates of effectiveness. They are generally 
based on a single outcome, which varies and is measured differently between 
studies. None of these estimates provide a comprehensive assessment of 
campaign effectiveness, which could act on a diverse range of short and long 
outcomes, from awareness to prevalence.  
The methods of establishing effectiveness in the included studies generally had 
some limitations; however, this is to be expected when studying the effects of 
population-level natural experiments, for which randomised controlled trials are 
not feasible. High quality population-level data on relevant outcomes is often not 
available, and therefore most studies rely on before and after surveys, making it 
difficult to take account of existing trends and confounding events. Regular cross-
sectional surveys such as the Smoking Toolkit study (used in two of the included 
studies).[24 26] help to improve the evidence for the effectiveness of such 
interventions.  
Of the three studies which modelled the cost-effectiveness of hypothetical 
campaigns, two did not seem to use an estimate of effectiveness based on a 
systematic review. This is an element which could be improved through 
adherence to a recognised checklist for the reporting of economic evaluations 
such as the BMJ checklist or the more recent CHEERS checklist.[14 28]  
All studies extrapolated campaign effectiveness estimates to obtain long-run 
estimates of life-years, QALYs or DALYs gained which inevitably introduced 
additional uncertainty into the findings; however, this is necessary due to the 
long lag to the onset of smoking-related morbidities. All studies reported 
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sensitivity analyses and/or confidence intervals which suggested that tobacco 
control campaigns are likely to be cost-effective even if effectiveness is lower 
and/or costs higher than assumed in the base case.  
Overall, the studies reviewed were of acceptable quality, but could have been 
improved in two key areas. Firstly, the interventions were often poorly described 
in terms of campaign content and intensity; albeit that in some cases existing 
papers or campaign report may contain additional details. Secondly, cost 
information was frequently inadequate. Again, these elements could be improved 
through adherence to a recognised checklist for the reporting of economic 
evaluations. 
Overall the variety in methodology and varying level of quality is in line with that 
identified in the review of studies on the cost-effectiveness of health 
communication programs mentioned above.[27] In addition, the evaluations were 
conducted in a limited range of countries - the UK, the USA and Australia - and 
the issue of generalisability was generally not addressed in the included studies. 
It is unclear whether the study findings can be transferred to other developed 
countries or developing countries. In future research it would be useful to explore 
the cost-effectiveness of adapting existing campaigns for use in developing 
countries, where the cost of developing and running new campaigns may be 
prohibitive. 
Despite some common limitations in the literature, and methodological 
inconsistencies between studies, the evidence reviewed in this study consistently 
suggests that tobacco control MMC offer good value for money, with estimates 
well within commonly used thresholds for cost-effectiveness. Given the nature of 
mass media campaigns, this is perhaps unsurprising; they deliver targeted 
messages to large populations of people at a low cost per head. The evidence is 
highly limited, however, and there is scope for further studies which adhere to 
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standard cost-effectiveness methodologies and reporting guidelines, particularly 
outside of the UK and the USA. 
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